Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells

Randomized Control Study of Nedaplatin or Cisplatin Concomitant with Other Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer

(2014) Chun-Hong Li et al.   Asian Pacific Journal of Cancer Prevention

Phase I Study of Nedaplatin Prior to S-1 in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

(2014) Dai Sato et al.   CHEMOTHERAPY

Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways

(2014) Juan Xia et al.   FOOD AND CHEMICAL TOXICOLOGY

Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer

(2014) D.J. Chu et al.   GENETICS AND MOLECULAR RESEARCH

Clinical Efficacy of Alternating Chemoradiotherapy by Conformal Radiotherapy Combined with Intracavitary Brachytherapy for High-risk Cervical Cancer

(2014) Kimiko Hirata et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

A comprehensive biological insight of trinuclear copper(ii)–tin(iv) chemotherapeutic anticancer drug entity: in vitro cytotoxicity and in vivo systemic toxicity studies

(2014) Yusra Zaidi et al.   Metallomics

Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism

(2014) Qingyu Zhang et al.   Scientific Reports

Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments

(2014) Evyenia Shaili   SCIENCE PROGRESS

Prospective Phase II Study of Image-guided Local Boost Using a Real-time Tumor-tracking Radiotherapy (RTRT) System for Locally Advanced Bladder Cancer

(2013) K. Nishioka et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells

(2013) Shixing Wu et al.   PLoS One

Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy

(2012) Carlos D Gamarra-Luques et al.   BMC CANCER

Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication

(2012) Y. Shen et al.   JOURNAL OF NEUROSCIENCE

The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy

(2012) Liting Deng et al.   Molecular Pain

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

(2011) Thomas B Brunner et al.   Radiation Oncology

STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner

(2009) Jonathan T. Sims et al.   BIOCHEMICAL PHARMACOLOGY